Title:
頸部障害の処置のためのロピナビルおよびリトナビル
Document Type and Number:
Japanese Patent JP7344911
Kind Code:
B2
Abstract:
The present invention concerns pharmaceutical compositions formulated for topical application that are useful in the treatment of HPV-related pathologies and in particular the treatment of premalignant and malignant conditions of the cervix. The compositions comprise a therapeutically effective amount of lopinavir and ritonavir in a pharmaceutically acceptable vehicle and wherein the weight ratio (w/w) of lopinavir:ritonavir is between 9:1 and 18:1.
Inventors:
Ian hampson
Hampson, Lynn
Hampson, Lynn
Application Number:
JP2020565864A
Publication Date:
September 14, 2023
Filing Date:
May 23, 2019
Export Citation:
Assignee:
Douglas Pharmaceuticals Limited
International Classes:
A61K31/427; A61K9/02; A61K9/06; A61K9/08; A61K31/505; A61K47/10; A61K47/12; A61K47/38; A61P31/20; A61P35/00; A61P43/00
Foreign References:
| WO2015059485A1 | ||||
| WO2013034927A1 |
Attorney, Agent or Firm:
Shoichi Okuyama
Tetsuo Matsushima
Ayako Nakamura
Soji Morimoto
Yu Tanaka
Koichi Tokumoto
Akiko Mizushima
Kohei Arihara
Tetsuo Matsushima
Ayako Nakamura
Soji Morimoto
Yu Tanaka
Koichi Tokumoto
Akiko Mizushima
Kohei Arihara